InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,727.52
(
0.26%
)
US TECH 100
19,493.60
(
0.27%
)
Dow Jones
41,790.72
(
-0.01%
)
Brent Oil
75.69
(
0.77%
)
Bitcoin
69,419.72
(
2.36%
)
Post# of 253531
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

biomaven0

Send PM Follow Ignore
Followers 82
Posts 4778
Boards Moderated 0
Alias Born 02/27/2007

biomaven0

Re: DewDiligence post# 114053

Friday, 02/04/2011 12:31:42 PM

Friday, February 04, 2011 12:31:42 PM

Post# of 253531

A key question is whether the drug will be able to distinguish bacteria from host as it goes about its killing business.



I don't believe that's much of a concern at all. In general all PYMX's drug candidates have much better selectivity than the body's own defensins.

The risk in their current trial in my view is whether the dose is high enough.

Peter

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up